We are live on
!
Find out more
NL
Navalign LLC Portfolio holdings
AUM
$429M
1-Year Est. Return
18.12%
This Quarter
Est. Return
+6.48%
1 Year Est. Return
+18.12%
3 Year Est. Return
+50.7%
5 Year Est. Return
+57.4%
10 Year Est. Return
–
AUM
$236M
AUM Growth
+$9.95M
(+4.4%)
Cap. Flow
+$9.98M
Cap. Flow
% of AUM
4.23%
Top 10 Holdings %
Top 10 Hldgs %
53%
Holding
129
New
6
Increased
61
Reduced
47
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$13.2M |
| 2 |
Vanguard International Dividend Appreciation ETF
VIGI
|
+$1.93M |
| 3 |
Allogene Therapeutics
ALLO
|
+$1.84M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$1.35M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$1.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.27M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.66M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.17M |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$1.07M |
| 5 |
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
|
+$965K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.65% |
| 2 | Healthcare | 7.3% |
| 3 | Financials | 5.08% |
| 4 | Industrials | 3.47% |
| 5 | Communication Services | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| – | – |
-5,533
| Closed | -$201K |
|
127
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.8B
| – | – |
-10,434
| Closed | -$327K |
|
|
128
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
| – | – |
-5,189
| Closed | -$1.07M |
|
|
ALXN
129
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-5,772
| Closed | -$883K |
|
Similar funds
BP
LJAF
CSNH
OA
RCWVOTCITCONY
MAM
GPGA
WPW
Navalign LLC's Q2 2021 Portfolio in Review
As of Q2 2021, Navalign LLC held 129 positions worth $236M, up 4.4% from $226M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Navalign LLC deployed $9.98M of net new capital in Q2 2021, opening 6 new positions and adding to 61 existing holdings. Its largest new stake was Allogene Therapeutics: 64,428 shares worth $1.68M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard Short-Term Bond ETF, an estimated $3.27M trimmed.
- Navalign LLC's largest Q2 2021 buy was Allogene Therapeutics: 64,428 shares worth $1.68M.
- Navalign LLC added most to iShares MSCI USA Momentum Factor ETF in Q2 2021, an estimated $13.2M increase.
- Navalign LLC's biggest Q2 2021 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.27M.
- Navalign LLC fully exited Vanguard Morningstar Total Stock Market ETF in Q2 2021, selling an estimated $1.07M.
- Navalign LLC's ten largest holdings make up 53% of its $236M portfolio in Q2 2021.
- Navalign LLC opened 6 new positions and closed 6 in Q2 2021.
- Navalign LLC's portfolio value rose 4.4% quarter-over-quarter to $236M.
Based on Navalign LLC's 13F filing for Q2 2021, filed 13 Aug 2021.